Heart Test Laboratories(HSCS) - 2025 Q2 - Quarterly Results

Financial Performance - HeartSciences Inc. reported financial results for the quarter ended October 31, 2024, with total revenue of $2.5 million, representing a 25% increase year-over-year[10] - The company achieved a gross margin of 60% for the quarter, up from 55% in the same period last year[10] - Operating expenses for the quarter were $1.8 million, a 10% increase compared to the previous year, primarily due to R&D investments[10] - HeartSciences reported a net loss of $500,000 for the quarter, an improvement from a net loss of $700,000 in the same quarter last year[10] User Growth - User data indicated a 30% increase in the number of active users, reaching 15,000 by the end of the quarter[10] Future Outlook - HeartSciences provided an optimistic outlook, projecting revenue growth of 20-25% for the next quarter[10] - The company is currently developing a new cardiac monitoring device expected to launch in Q2 2025[10] - HeartSciences plans to expand its market presence in Europe, targeting a 15% market share by the end of 2025[10] Strategic Initiatives - The company is exploring potential acquisition opportunities to enhance its product portfolio and market reach[10] - The company emphasized its commitment to innovation and strategic partnerships to drive future growth[10]